{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:03:51Z","timestamp":1779714231647,"version":"3.53.1"},"reference-count":22,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Given the limited and conflicting evidence regarding both the role of bisphosphonate (BP) use and the risk factors for postoperative hypocalcemia, as well as ongoing clinical hesitation toward preoperative BP use due to concerns about the occurrence of hypocalcemia, we aimed to investigate their association in patients with primary hyperparathyroidism (PHPT). Materials and Methods: A total of 73 patients undergoing parathyroidectomy were included, with 22 in the BP-positive (zoledronate) group and 51 in the BP-negative group. In BP-treated patients, biochemical values obtained after zoledronate infusion but before surgery were used as the preoperative baseline for perioperative comparisons, whereas pre-infusion calcium values were used only to characterize the clinical indication for treatment. Factors associated with postoperative hypocalcemia were evaluated using hypocalcemia as a dichotomous outcome. Results: Postoperative hypocalcemia was more frequent in BP-treated patients (27.3% vs. 3.9%, p = 0.008). However, in multivariable analysis including alkaline phosphatase (ALP), the association between BP use and hypocalcemia was attenuated and no longer statistically significant (OR 4.81, 95% CI 0.74\u201331.30; p = 0.100). ALP was independently associated with hypocalcemia (OR 1.016, 95% CI 1.001\u20131.031; p = 0.040). Additionally, hypocalcemia was associated with a shorter infusion-to-surgery interval (median 10 vs. 72 days, p = 0.0045) among BP-treated patients. Conclusions: Although hypocalcemia was more frequent among patients receiving preoperative zoledronate, this association was attenuated after adjustment for alkaline phosphatase and may reflect underlying disease severity. Alkaline phosphatase was independently associated with postoperative hypocalcemia, supporting the role of increased bone turnover. Given the limited number of events, an independent effect of zoledronate cannot be excluded, and treatment timing may warrant further investigation.<\/jats:p>","DOI":"10.3390\/jcm15114080","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:57:44Z","timestamp":1779710264000},"page":"4080","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Zoledronate Use and Risk of Postoperative Hypocalcemia After Parathyroidectomy for Primary Hyperparathyroidism: A Comparative Retrospective Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-3805","authenticated-orcid":false,"given":"\u00dcmit","family":"\u00c7avdar","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Duman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5459-366X","authenticated-orcid":false,"given":"\u00d6zlem","family":"Eren","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-553X","authenticated-orcid":false,"given":"Mehmet Sercan","family":"Ert\u00fcrk","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-0191","authenticated-orcid":false,"given":"Serkan","family":"Kara\u0131sl\u0131","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine \u00d6zlem","family":"G\u00fcr","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda G\u00fccek","family":"Haciyanli","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f \u00d6nder","family":"Pamuk","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-1405","authenticated-orcid":false,"given":"Mehmet","family":"Haciyanli","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Atat\u00fcrk Training and Research Hospital, Katip \u00c7elebi University, 35360 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1749","DOI":"10.1210\/clinem\/dgad267","article-title":"Incidence of Primary Hyperparathyroidism in the Current Era: Have We Finally Reached a Steady State?","volume":"108","author":"Wermers","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dandurand, K., Ali, D.S., and Khan, A.A. (2021). Primary hyperparathyroidism: A narrative review of diagnosis and medical management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081604"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cironi, K.A., Issa, P.P., Albuck, A.L., McCarthy, C., Rezvani, L., Hussein, M., Luo, X., Shama, M., Toraih, E., and Kandil, E. (2023). Comparison of Medical Management versus Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism: A Meta-Analysis. Cancers, 15.","DOI":"10.3390\/cancers15123085"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/2359-3997000000207","article-title":"Hypocalcemia development in patients operated for primary hyperparathyroidism: Can it be predicted preoperatively?","volume":"60","author":"Kaya","year":"2016","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Carsote, M., and Nistor, C. (2023). Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism. Diagnostics, 13.","DOI":"10.3390\/diagnostics13111953"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Xu, J., Kong, N., Bai, N., Zhang, Z., Cui, A., Tan, S., and Xu, Q. (2024). Identification of novel risk factors for postoperative severe hypocalcemia in patients with primary hyperparathyroidism undergoing parathyroidectomy: A case control study. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01620-6"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjoto.2018.01.006","article-title":"Thirty-day readmissions following parathyroidectomy: Evidence from the National Readmissions Database, 2013\u20132014","volume":"39","author":"Kravietz","year":"2018","journal-title":"Am. J. Otolaryngol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cen.15268","article-title":"The Effect of Preoperative Biochemical Parameters on the Development of Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism","volume":"103","author":"Hadi","year":"2025","journal-title":"Clin. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101701","DOI":"10.1016\/j.ando.2025.101701","article-title":"Chapter 12: Preparation for parathyroid surgery","volume":"86","author":"Lecoq","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00774-005-0680-x","article-title":"Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism","volume":"24","author":"Lee","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1440-1797.2007.00806.x","article-title":"Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome","volume":"12","author":"Davenport","year":"2007","journal-title":"Nephrology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/2230-8210.196023","article-title":"Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism","volume":"21","author":"Mayilvaganan","year":"2017","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.14310\/horm.2002.1286","article-title":"Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid","volume":"9","author":"Corsello","year":"2010","journal-title":"Hormones"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bone.2006.04.032","article-title":"Severe hypocalcemia following bisphosphonate treatment in a patient with Paget\u2019s disease of bone","volume":"39","author":"Whitson","year":"2006","journal-title":"Bone"},{"key":"ref_18","first-page":"108","article-title":"Role of Bisphosphonates in the Prevention of Postoperative Hungry Bone Syndrome in Primary Hyperparathyroidism: A Meta-Analysis and Need for Randomized Controlled Trials","volume":"71","author":"Pal","year":"2020","journal-title":"Drug Res."},{"key":"ref_19","first-page":"310","article-title":"Risk factors and evolution of calcium and parathyroid hormone levels in hungry bone syndrome after parthyroidectomy for primary hyperparathyroidism","volume":"67","year":"2020","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8285521","DOI":"10.1155\/ije\/8285521","article-title":"Bisphosphonate Therapy and the Occurrence of the Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism","volume":"2025","author":"Etemadi","year":"2025","journal-title":"Int. J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The Efficacy and Safety of Medical and Surgical Therapy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"37","author":"Ye","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","article-title":"Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: A systematic review and meta-analysis of randomized-controlled studies","volume":"44","author":"Anagnostis","year":"2020","journal-title":"J. Endocrinol. Investig."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4080\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:21:35Z","timestamp":1779711695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15114080"],"URL":"https:\/\/doi.org\/10.3390\/jcm15114080","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}